21st Century Cures Act Includes Programs to Benefit Dystonia Community
Yesterday President Obama signed into law the 21st Century Cures Act , a bi-partisan, multiyear effort that will support biomedical research and drug discovery. Cures will provide $4.8 billion to the National Institutes of Health for the BRAIN initiative, the precision medicine program, cancer research, and regenerative medicine in adults. The legislation will also provide $500 million to the Food and Drug Administration.
We are still reviewing the legislation but thought you would want to know of some of programs that will benefit the dystonia community. These include the development of a National Neurological Conditions Surveillance System; provisions to the FDA for the authority to apply the humanitarian device exemption to devices that treat disorders that affect up to 8,000 individuals (up from current cap of 4,000); and additional provisions to support the work of young investigators and the sharing of research data. Cures will support reducing barriers to researcher collaboration, and support the FDA to further incorporate the patient perspective, work to modernize clinical trials, develop new pathways to approve treatments and devices.
We applaud the administration’s support of this landmark legislation and congratulate Representatives Fred Upton of Michigan and Diane DeGette of Colorado for their tireless efforts to champion this Act.
Accelerating Research & Inspiring Hope
The Dystonia Medical Research Foundation (DMRF) has served the dystonia community since 1976. Join us in our global effort to find a cure.